Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
- PMID: 35369322
- PMCID: PMC8965840
- DOI: 10.3389/fcvm.2022.834967
Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
Abstract
Background: Recent studies of fibroblast growth factor 21 (FGF21), first recognized as a regulator of glucose and lipid metabolism, have found that the level of in serum FGF21 is associated with the prognosis of many cardiovascular diseases, but its relationship to acute heart failure (AHF) patients remains unknown. Our study aimed to investigate whether circulating FGF21 could predict the short-term prognosis of AHF patients.
Methods: Four hundred and two AHF patients and 19 healthy controls were recruited into the prospective cohort study, and blood samples of participants were collected, in tubes without anticoagulant, within the first 24 h after hospital admission. Serum FGF21 levels were detected by enzyme-linked immunosorbent assay (ELISA). All patients were followed-up at least 6 months after discharge. The primary endpoint was all-cause death, and secondary endpoint was a composite endpoint of death and heart failure readmission. Mortality and composite end point events were analyzed using Kaplan-Meier curves. ROC curves compared the difference between the FGF21 and NT-proBNP in predicting 3- and 6-months mortality. Time-to-event data were evaluated using Kaplan-Meier estimation and Cox proportional hazards models.
Results: In the present study, the serum FGF21 concentrations were significantly higher in the 402 AHF patients enrolled, compared with the 19 healthy controls (p < 0.001). The average age was 70 (±12) years, and 58% were males. Participants were divided into two groups according to the median FGF21 level (262 pg/ml): a high FGF21 group (n = 201, FGF21 ≥ 262 pg/ml) and low FGF21 group (n = 201, FGF21 <262 pg/ml). FGF21 was positively correlated with NT-proBNP, BUN, AST, creatinine and cholesterol, and negatively correlated with ALB and HDL. After a median follow-up of 193 days, the high FGF21 group had higher mortality and composite endpoint events compared with the low FGF21 group (HR: 3.91, 95% CI 2.21-6.92, p <0.001), even after adjusting for NT-proBNP (HR: 3.17, 95% CI 1.72-5.81, p < 0.001). ROC analysis shows that FGF21 was better than NT-proBNP in predicting death at both 3 (AUC, 0.77 vs. 0.63, p < 0.001) and 6 months (AUC, 0.78 vs. 0.66).
Conclusion: High baseline FGF21 levels are associated with adverse clinical outcomes in AHF patients. Serum FGF21 might be a potential predictive biomarker of AHF patients.
Keywords: FGF21; acute heart failure; biomarker; death; prognosis.
Copyright © 2022 Wu, Wu, Yan, Gao, Zhu, Yue, Li and Tan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8965840/bin/fcvm-09-834967-g0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8965840/bin/fcvm-09-834967-g0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8965840/bin/fcvm-09-834967-g0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8965840/bin/fcvm-09-834967-g0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8965840/bin/fcvm-09-834967-g0005.gif)
Similar articles
-
Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.Cardiology. 2021;146(1):27-33. doi: 10.1159/000509239. Epub 2020 Dec 2. Cardiology. 2021. PMID: 33264784
-
[Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Aug 24;48(8):661-668. doi: 10.3760/cma.j.cn112148-20200309-00175. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32847322 Chinese.
-
[Diagnostic value of copeptin and cancer antigen 125 in acute heart failure patients with atrial fibrillation and their correlations with short-term cardiovascular events].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1024-1028. doi: 10.3760/cma.j.issn.2095-4352.2018.011.003. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30541639 Chinese.
-
Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia.J Ophthalmic Vis Res. 2020 Feb 2;15(1):38-44. doi: 10.18502/jovr.v15i1.5940. eCollection 2020 Jan-Mar. J Ophthalmic Vis Res. 2020. PMID: 32095207 Free PMC article. Review.
-
Fibroblast growth factor 21 in heart failure.Heart Fail Rev. 2023 Jan;28(1):261-272. doi: 10.1007/s10741-022-10268-0. Epub 2022 Aug 27. Heart Fail Rev. 2023. PMID: 36028609 Free PMC article. Review.
Cited by
-
Mitochondrial dysfunction affects hepatic immune and metabolic remodeling in patients with hepatitis B virus-related acute-on-chronic liver failure.World J Gastroenterol. 2024 Feb 28;30(8):881-900. doi: 10.3748/wjg.v30.i8.881. World J Gastroenterol. 2024. PMID: 38516248 Free PMC article.
-
The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China.BMC Endocr Disord. 2023 Sep 1;23(1):188. doi: 10.1186/s12902-023-01426-y. BMC Endocr Disord. 2023. PMID: 37658393 Free PMC article.
-
The secretome as a biomarker and functional agent in heart failure.J Cardiovasc Aging. 2023 Jul;3(3):27. doi: 10.20517/jca.2023.15. Epub 2023 Jun 9. J Cardiovasc Aging. 2023. PMID: 37484982 Free PMC article.
-
Increased serum fibroblast growth factor 21 levels are associated with adverse clinical outcomes after intracerebral hemorrhage.Front Neurosci. 2023 May 5;17:1117057. doi: 10.3389/fnins.2023.1117057. eCollection 2023. Front Neurosci. 2023. PMID: 37214383 Free PMC article.
-
Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis.Front Endocrinol (Lausanne). 2023 Feb 28;14:1108234. doi: 10.3389/fendo.2023.1108234. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36926038 Free PMC article.
References
-
- van den Berge JC, Constantinescu AA, van Domburg RT, Brankovic M, Deckers JW, Akkerhuis, et al. . Renal function and anemia in relation to short- and long-term prognosis of patients with acute heart failure in the period 1985-2008: a clinical cohort study. PLoS ONE. (2018) 13:e0201714. 10.1371/journal.pone.0201714 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous